LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges.

    Lee, Choongho

    Marine drugs

    2020  Volume 18, Issue 9

    Abstract: ... amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans ... attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and ... CGs) were expected to be the first clinically applicable microbicides that could prevent various ...

    Abstract Different kinds of red algae are enriched with chemically diverse carbohydrates. In particular, a group of sulfated polysaccharides, which were isolated from the cell walls of red algae, gained a large amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans (CGs) were expected to be the first clinically applicable microbicides that could prevent various viral infections due to their superior antiviral potency and desirable safety profiles in subclinical studies. However, their anticipated beneficial effects could not be validated in human studies. To assess the value of a second attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and clinical development processes of CG-based microbicides need to be thoroughly re-evaluated. In this review, the in vitro toxicities; in vivo safety profiles; and in vitro, ex vivo, and in vivo antiviral activities of CGs are summarized according to the study volume of their target viruses, which include human immunodeficiency virus, herpesviruses, respiratory viruses, human papillomavirus, dengue virus, and other viruses along with a description of their antiviral modes of action and development of antiviral resistance. This evaluation of the strengths and weaknesses of CGs will help provide future research directions that may lead to the successful development of CG-based antimicrobial prophylactics.
    MeSH term(s) Animals ; Antiviral Agents/adverse effects ; Antiviral Agents/isolation & purification ; Antiviral Agents/therapeutic use ; Carrageenan/adverse effects ; Carrageenan/isolation & purification ; Carrageenan/therapeutic use ; Host-Pathogen Interactions ; Humans ; Rhodophyta/chemistry ; Virus Diseases/drug therapy ; Virus Diseases/virology
    Chemical Substances Antiviral Agents ; Carrageenan (9000-07-1)
    Keywords covid19
    Language English
    Publishing date 2020-08-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2175190-0
    ISSN 1660-3397 ; 1660-3397
    ISSN (online) 1660-3397
    ISSN 1660-3397
    DOI 10.3390/md18090435
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges

    Lee, Choongho

    Abstract: ... amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans ... attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and ... CGs) were expected to be the first clinically applicable microbicides that could prevent various ...

    Abstract Different kinds of red algae are enriched with chemically diverse carbohydrates. In particular, a group of sulfated polysaccharides, which were isolated from the cell walls of red algae, gained a large amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans (CGs) were expected to be the first clinically applicable microbicides that could prevent various viral infections due to their superior antiviral potency and desirable safety profiles in subclinical studies. However, their anticipated beneficial effects could not be validated in human studies. To assess the value of a second attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and clinical development processes of CG-based microbicides need to be thoroughly re-evaluated. In this review, the in vitro toxicities; in vivo safety profiles; and in vitro, ex vivo, and in vivo antiviral activities of CGs are summarized according to the study volume of their target viruses, which include human immunodeficiency virus, herpesviruses, respiratory viruses, human papillomavirus, dengue virus, and other viruses along with a description of their antiviral modes of action and development of antiviral resistance. This evaluation of the strengths and weaknesses of CGs will help provide future research directions that may lead to the successful development of CG-based antimicrobial prophylactics.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #727938
    Database COVID19

    Kategorien

  3. Article: Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges

    Lee, Choongho

    Marine drugs. 2020 Aug. 21, v. 18, no. 9

    2020  

    Abstract: ... amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans ... attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and ... CGs) were expected to be the first clinically applicable microbicides that could prevent various ...

    Abstract Different kinds of red algae are enriched with chemically diverse carbohydrates. In particular, a group of sulfated polysaccharides, which were isolated from the cell walls of red algae, gained a large amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans (CGs) were expected to be the first clinically applicable microbicides that could prevent various viral infections due to their superior antiviral potency and desirable safety profiles in subclinical studies. However, their anticipated beneficial effects could not be validated in human studies. To assess the value of a second attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and clinical development processes of CG-based microbicides need to be thoroughly re-evaluated. In this review, the in vitro toxicities; in vivo safety profiles; and in vitro, ex vivo, and in vivo antiviral activities of CGs are summarized according to the study volume of their target viruses, which include human immunodeficiency virus, herpesviruses, respiratory viruses, human papillomavirus, dengue virus, and other viruses along with a description of their antiviral modes of action and development of antiviral resistance. This evaluation of the strengths and weaknesses of CGs will help provide future research directions that may lead to the successful development of CG-based antimicrobial prophylactics.
    Keywords Dengue virus ; Herpesviridae ; Human immunodeficiency virus ; Papillomaviridae ; Rhodophyta ; anti-infective agents ; antiviral properties ; carrageenan ; humans ; lead ; mechanism of action ; research ; viruses ; volume
    Language English
    Dates of publication 2020-0821
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    Note NAL-light
    ZDB-ID 2175190-0
    ISSN 1660-3397
    ISSN 1660-3397
    DOI 10.3390/md18090435
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Carrageenans as Broad-Spectrum Microbicides

    Choongho Lee

    Marine Drugs, Vol 18, Iss 435, p

    Current Status and Challenges

    2020  Volume 435

    Abstract: ... amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans ... attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and ... CGs) were expected to be the first clinically applicable microbicides that could prevent various ...

    Abstract Different kinds of red algae are enriched with chemically diverse carbohydrates. In particular, a group of sulfated polysaccharides, which were isolated from the cell walls of red algae, gained a large amount of attention due to their broad-spectrum antimicrobial activities. Within that group, carrageenans (CGs) were expected to be the first clinically applicable microbicides that could prevent various viral infections due to their superior antiviral potency and desirable safety profiles in subclinical studies. However, their anticipated beneficial effects could not be validated in human studies. To assess the value of a second attempt at pharmacologically developing CGs as a new class of preventive microbicides, all preclinical and clinical development processes of CG-based microbicides need to be thoroughly re-evaluated. In this review, the in vitro toxicities; in vivo safety profiles; and in vitro, ex vivo, and in vivo antiviral activities of CGs are summarized according to the study volume of their target viruses, which include human immunodeficiency virus, herpesviruses, respiratory viruses, human papillomavirus, dengue virus, and other viruses along with a description of their antiviral modes of action and development of antiviral resistance. This evaluation of the strengths and weaknesses of CGs will help provide future research directions that may lead to the successful development of CG-based antimicrobial prophylactics.
    Keywords sulfated polysaccharides ; carrageenans (CGs) ; broad-spectrum microbicides ; in vitro and in vivo toxicity ; in vitro ; ex vivo ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top